InvestorsHub Logo
Post# of 200622
Next 10
Followers 5
Posts 156
Boards Moderated 0
Alias Born 03/30/2019

Re: dinogreeves post# 6513

Monday, 07/29/2019 9:04:16 PM

Monday, July 29, 2019 9:04:16 PM

Post# of 200622
I don't disagree with what you are saying. Like I said, I think there are many benefits to having Ron on board. All I am saying is that even without him, it's not as if we are dead in the water. Jody Read built a $40mm a year sales business in the medical space. The rest of management has a ton of relevant experience and connections. They have built the product, generated sales, and built this all without Ron. Sure Ron could add some value, but who is to say the current team can't generate similar value.

My point being that with or without this deal, I don't think there is reason to panic. Listing on the Canadian exchange is as simple as a R/M with a shell company on the exchange. Current management can accomplish that. Current management can also continue to grow sales, albeit it may or may not be at a slower pace (something well never be able to know for sure).

The major kicker is the debt. I would much prefer Ron's debt capital to Power Up Lending lmao. So unless the company can find traditional inventory lending, I agree that Ron offers something essential with retiring debt. I just don't want to see the share structure go to hell in the process. If I see the authorized shares get bumped to anything above 500mm without restrictions on management sales, I am out of here. Too hard to get the price to move more than a few cents here or there.